SAN FRANCISCO, Nov. 02, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today commented on the Centers for Medicare and Medicaid Services (CMS) Calendar Year 2022 Medicare Physician Fee Schedule (MPFS) Final Rule. The Final […]
Author: Ken Dropiewski
Zynex Announces 2021 Third Quarter Earnings
ENGLEWOOD, Colo., Nov. 2, 2021 /PRNewswire/ — 2021 Third Quarter Revenue increased 74% year over year to $34.8 million Orders increased 70% Record net income of $6.1 million; Diluted EPS $0.17 Adjusted EBITDA $9.3 million Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, […]
Ionis reports third quarter 2021 financial results and recent business achievements
Olezarsen (IONIS-APOCIII-L Rx) Phase 3 CORE study in patients with sHTG initiated Donidalorsen (IONIS-PKK-L Rx) Phase 2 data to be presented at ACAAI Annual Meeting; Phase 3 initiation on track for year-end Tofersen Phase 3 VALOR study missed primary endpoint; signs of reduced disease progression observed across multiple secondary and […]
Amgen Reports Third Quarter 2021 Financial Results
THOUSAND OAKS, Calif., Nov. 2, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2021. Key results include: Total revenues increased 4% to $6.7 billion in comparison to the third quarter of 2020, driven by higher unit demand, partially offset by lower net selling prices. Product sales increased 4% globally, […]
United Therapeutics Corporation Reports Third Quarter 2021 Financial Results
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Nov. 3, 2021 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today announced its financial results for the quarter ended September 30, 2021. Total revenue in the third quarter of 2021 grew 17% year over […]
Peerbridge Health and BetterNight partnership addresses unmet need in AFib and Sleep Apnea Coordinated Care
A unique new care management solution will accelerate diagnosis and treatment of AFib and sleep apnea patients in cardiology practices NEW YORK, Nov. 3, 2021 /PRNewswire/ — Peerbridge Health and BetterNight are partnering on a unique new care management solution designed specifically for cardiology practices for earlier identification, treatment, and optimization of […]
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update
On-going Phase 2b clinical trial (ASPEN-COVID-19) evaluating rNAPc2 as a potential treatment for COVID-19 DSMC interim analysis of safety and efficacy data from ASPEN-COVID-19 completed with recommendation to continue trial to completion with no modifications Topline data anticipated in first quarter of 2022 Cash and cash equivalents of $58.3 million […]
Amarin Reports Third Quarter 2021 Financial Results and Provides Business Update
Launched VAZKEPA in Germany with Multiple European Country Launches Expected in 2022 Introduced New Go-to-Market Strategy in U.S. to Enhance Awareness and Drive Demand for VASCEPA® Plans for Regulatory Filings and Approvals of VASCEPA in Several Additional Countries in 2022 Company to Host Conference Call Today at 7:30 a.m. ET DUBLIN, […]
Colibri Heart Valve Initiates International CE Mark-enabling Pilot Study of Second-Generation TAVI System
LOUISVILLE, CO , Nov. 03, 2021 (GLOBE NEWSWIRE) — Colibri Heart Valve LLC, a privately held emerging medical device company, today announced the initiation of an international pilot study of the Colibri transcatheter aortic valve implantation (TAVI) system. Bernard Chevalier, M.D., an interventional cardiologist at Hôpital Privé Jacques Cartier, is serving […]
Sequana Medical receives MDSAP certification and expands its Quality Management System towards North America
Ghent, Belgium – 3 November 2021 – Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces it has received Medical Device Single Audit Program (MDSAP) certification from its auditing organisation British Standards Institution (BSI), thereby expanding its […]
Recent
Popular
- No commented posts yet